サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1538540

自己投与非経口薬市場レポート：2030年までの動向、予測、競合分析

Self-Administered Parenteral Market Report: Trends, Forecast and Competitive Analysis to 2030

出版日
発行
Lucintel
ページ情報
英文 150 Pages
納期
3営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円

ご注意:　DRM (デジタル著作権管理システム) 付PDFになります。
制限内容は、上記ライセンスの[詳細]アイコンをクリックしてご確認ください。

自己投与非経口薬市場レポート：2030年までの動向、予測、競合分析
出版日: 2024年07月01日
発行: Lucintel
ページ情報: 英文 150 Pages
納期: 3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

自己投与非経口薬の動向と予測

世界の自己投与非経口薬市場は、2024年から2030年にかけてCAGR 5.5％で成長すると予測されます。この市場の主な促進要因は、特殊薬剤と生物製剤の重要性の高まり、在宅治療の選択肢の受け入れ拡大、スマート注射ツールの使用拡大です。世界の自己投与非経口薬市場の将来は、心血管疾患、糖尿病、骨粗鬆症、疼痛管理、ホルモン補充市場に機会があり、有望視されています。

セグメント別自己投与非経口薬

この調査には、世界の自己投与非経口薬の製品タイプ別、使用方法別、流通チャネル別、用途別、地域別の予測が含まれています。

自己投与非経口薬市場の洞察

Lucintel社は、実用的で安全な薬物送達システムに対する需要の高まりから、プレフィルドシリンジが予測期間中に最も高い成長を遂げると予測しています。

この市場の中では、疼痛管理が予測期間中に最も高い成長を遂げると予測されます。

アジア太平洋は予測期間中に最も高い成長を示すと予想されます。

よくある質問

Q1.市場の成長予測は：

A1.世界の自己投与非経口薬市場は、2024年から2030年にかけてCAGR 5.5%で成長すると予想されています。

Q2.市場の成長に影響を与える主な促進要因は：

A2.この市場の主な促進要因は、特殊医薬品・生物製剤の重要性の高まり、在宅治療の選択肢の受け入れ拡大、スマート注射ツールの使用拡大です。

Q3.市場の主要セグメントは：

A3.自己投与非経口薬市場の将来は、心血管疾患、糖尿病、骨粗鬆症、疼痛管理、ホルモン補充市場に機会があり、有望です。

Q4.市場の主要企業は：

A4.自己投与型非経口薬の主要企業の一部は以下の通りです：

  • Becton, Dickinson and Company
  • scPharmaceuticals
  • Harro Hofliger
  • Owen Mumford
  • Haselmeier
  • Stevanato Group
  • Ypsomed AG
  • Solteam Group
  • AstraZeneca
  • Enable Injections

Q5.今後、最大となる市場セグメントは：

A5.Lucintelは、プレフィルドシリンジは実用的で安全な薬物送達システムに対する需要の高まりから、予測期間中に最も高い成長が見込まれると予測しています。

Q6.市場において、今後5年間に最大になると予想される地域は：

A6.APACは予測期間中最も高い成長が見込まれます。

Q7.レポートのカスタマイズは可能か：

A7.はい、Lucintelは追加費用なしで10％のカスタマイズを提供します。

目次

第1章 エグゼクティブサマリー

第2章 世界の自己投与非経口薬市場：市場力学

  • イントロダクション、背景、分類
  • サプライチェーン
  • 業界の促進要因と課題

第3章 2018年から2030年までの市場動向と予測分析

  • マクロ経済動向（2018～2023年）と予測（2024～2030年）
  • 世界の自己投与非経口薬市場の動向（2018～2023年）と予測（2024～2030年）
  • 製品タイプ別世界の自己投与非経口薬市場
    • プレフィルドシリンジ
    • オートインジェクター
    • ペン型注射器
    • その他
  • 使用方法別世界の自己投与非経口薬市場
    • 使い捨て
    • 再利用可能
  • 流通チャネル別世界の自己投与非経口薬市場
    • 病院薬局
    • オンライン薬局
    • 在宅医療提供者
    • 専門クリニック
    • その他
  • 用途別世界の自己投与非経口薬市場
    • 心血管疾患
    • 糖尿病
    • 骨粗鬆症
    • 疼痛管理
    • ホルモン補充療法
    • その他

第4章 2018年から2030年までの地域別市場動向と予測分析

  • 地域別世界の自己投与非経口薬市場
  • 北米の自己投与非経口薬市場
  • 欧州の自己投与非経口薬市場
  • アジア太平洋地域の自己投与非経口薬市場
  • その他地域自己投与非経口薬市場

第5章 競合分析

  • 製品ポートフォリオ分析
  • 業務統合
  • ポーターのファイブフォース分析

第6章 成長機会と戦略分析

  • 成長機会分析
    • 製品タイプ別の世界の自己投与非経口薬市場の成長機会
    • 使用方法別世界の自己投与非経口薬市場の成長機会
    • 流通チャネル別世界の自己投与非経口薬市場の成長機会
    • 用途別世界の自己投与非経口薬市場の成長機会
    • 地域別の世界の自己投与非経口薬市場の成長機会
  • 世界の自己投与非経口薬市場の新たな動向
  • 戦略分析
    • 新製品開発
    • 世界の自己投与非経口薬市場の生産能力拡大
    • 世界の自己投与非経口薬市場における合併、買収、合弁事業
    • 認証とライセンシング

第7章 主要企業の企業プロファイル

  • Becton, Dickinson and Company
  • scPharmaceuticals
  • Harro Hofliger
  • Owen Mumford
  • Haselmeier
  • Stevanato Group
  • Ypsomed AG
  • Solteam Group
  • AstraZeneca
  • Enable Injections
目次

Self-Administered Parenteral Trends and Forecast

The future of the global self-administered parenteral market looks promising with opportunities in the cardiovascular disease, diabetes, osteoporosis, pain management, and hormone replacement markets. The global self-administered parenteral market is expected to grow with a CAGR of 5.5% from 2024 to 2030. The major drivers for this market are growing significance of specialty drugs & biologics, increasing acceptance of options for home-based therapy, and growing use of smart injection tools.

A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.

Self-Administered Parenteral by Segment

The study includes a forecast for the global self-administered parenteral by product type, usage, distribution channel, application, and region.

Self-Administered Parenteral Market by Product Type [Shipment Analysis by Value from 2018 to 2030]:

  • Pre-Filled Syringes
  • Auto injectors
  • Pen Injectors
  • Others

Self-Administered Parenteral Market by Usage [Shipment Analysis by Value from 2018 to 2030]:

  • Disposable
  • Reusable

Self-Administered Parenteral Market by Distribution Channel [Shipment Analysis by Value from 2018 to 2030]:

  • Hospital Pharmacies
  • Online Pharmacies
  • Home Healthcare Providers
  • Specialty Clinics
  • Others

Self-Administered Parenteral Market by Application [Shipment Analysis by Value from 2018 to 2030]:

  • Cardiovascular Diseases
  • Diabetes
  • Osteoporosis
  • Pain Management
  • Hormone Replacement
  • Others

Self-Administered Parenteral Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Self-Administered Parenteral Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies self-administered parenteral companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the self-administered parenteral companies profiled in this report include-

  • Becton, Dickinson and Company
  • scPharmaceuticals
  • Harro Hofliger
  • Owen Mumford
  • Haselmeier
  • Stevanato Group
  • Ypsomed AG
  • Solteam Group
  • AstraZeneca
  • Enable Injections

Self-Administered Parenteral Market Insights

Lucintel forecasts that pre-filled syringe is expected to witness the highest growth over the forecast period due to its growing demand for practical and safe medicine delivery systems.

Within this market, pain management is expected to witness the highest growth over the forecast period.

APAC is expected to witness the highest growth over the forecast period.

Features of the Global Self-Administered Parenteral Market

Market Size Estimates: Self-administered parenteral market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Self-administered parenteral market size by various segments, such as by product type, usage, distribution channel, application, and region in terms of value ($B).

Regional Analysis: Self-administered parenteral market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different product types, usages, distribution channels, applications, and regions for the self-administered parenteral market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the self-administered parenteral market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the growth forecast for self-administered parenteral market?

Answer: The global self-administered parenteral market is expected to grow with a CAGR of 5.5% from 2024 to 2030.

Q2. What are the major drivers influencing the growth of the self-administered parenteral market?

Answer: The major drivers for this market are growing significance of specialty drugs & biologics, increasing acceptance of options for home-based therapy, and growing use of smart injection tools.

Q3. What are the major segments for self-administered parenteral market?

Answer: The future of the self-administered parenteral market looks promising with opportunities in the cardiovascular disease, diabetes, osteoporosis, pain management, and hormone replacement markets.

Q4. Who are the key self-administered parenteral market companies?

Answer: Some of the key self-administered parenteral companies are as follows:

  • Becton, Dickinson and Company
  • scPharmaceuticals
  • Harro Hofliger
  • Owen Mumford
  • Haselmeier
  • Stevanato Group
  • Ypsomed AG
  • Solteam Group
  • AstraZeneca
  • Enable Injections

Q5. Which self-administered parenteral market segment will be the largest in future?

Answer: Lucintel forecasts that pre-filled syringe is expected to witness the highest growth over the forecast period due to its growing demand for practical and safe medicine delivery systems.

Q6. In self-administered parenteral market, which region is expected to be the largest in next 5 years?

Answer: APAC is expected to witness the highest growth over the forecast period.

Q7. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the self-administered parenteral market by product type (pre-filled syringes, auto injectors, pen injectors, and others), usage (disposable and reusable), distribution channel (hospital pharmacies, online pharmacies, home healthcare providers, specialty clinics, and others), application (cardiovascular diseases, diabetes, osteoporosis, pain management, hormone replacement, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Self-Administered Parenteral Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Self-Administered Parenteral Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Self-Administered Parenteral Market by Product Type
    • 3.3.1: Pre-Filled Syringes
    • 3.3.2: Auto injectors
    • 3.3.3: Pen Injectors
    • 3.3.4: Others
  • 3.4: Global Self-Administered Parenteral Market by Usage
    • 3.4.1: Disposable
    • 3.4.2: Reusable
  • 3.5: Global Self-Administered Parenteral Market by Distribution Channel
    • 3.5.1: Hospital Pharmacies
    • 3.5.2: Online Pharmacies
    • 3.5.3: Home Healthcare Providers
    • 3.5.4: Specialty Clinics
    • 3.5.5: Others
  • 3.6: Global Self-Administered Parenteral Market by Application
    • 3.6.1: Cardiovascular Diseases
    • 3.6.2: Diabetes
    • 3.6.3: Osteoporosis
    • 3.6.4: Pain Management
    • 3.6.5: Hormone Replacement
    • 3.6.6: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Self-Administered Parenteral Market by Region
  • 4.2: North American Self-Administered Parenteral Market
    • 4.2.1: North American Self-Administered Parenteral Market by Product Type: Pre-Filled Syringes, Auto injectors, Pen Injectors, and Others
    • 4.2.2: North American Self-Administered Parenteral Market by Application: Cardiovascular Diseases, Diabetes, Osteoporosis, Pain Management, Hormone Replacement, and Others
  • 4.3: European Self-Administered Parenteral Market
    • 4.3.1: European Self-Administered Parenteral Market by Product Type: Pre-Filled Syringes, Auto injectors, Pen Injectors, and Others
    • 4.3.2: European Self-Administered Parenteral Market by Application: Cardiovascular Diseases, Diabetes, Osteoporosis, Pain Management, Hormone Replacement, and Others
  • 4.4: APAC Self-Administered Parenteral Market
    • 4.4.1: APAC Self-Administered Parenteral Market by Product Type: Pre-Filled Syringes, Auto injectors, Pen Injectors, and Others
    • 4.4.2: APAC Self-Administered Parenteral Market by Application: Cardiovascular Diseases, Diabetes, Osteoporosis, Pain Management, Hormone Replacement, and Others
  • 4.5: ROW Self-Administered Parenteral Market
    • 4.5.1: ROW Self-Administered Parenteral Market by Product Type: Pre-Filled Syringes, Auto injectors, Pen Injectors, and Others
    • 4.5.2: ROW Self-Administered Parenteral Market by Application: Cardiovascular Diseases, Diabetes, Osteoporosis, Pain Management, Hormone Replacement, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Self-Administered Parenteral Market by Product Type
    • 6.1.2: Growth Opportunities for the Global Self-Administered Parenteral Market by Usage
    • 6.1.3: Growth Opportunities for the Global Self-Administered Parenteral Market by Distribution Channel
    • 6.1.4: Growth Opportunities for the Global Self-Administered Parenteral Market by Application
    • 6.1.5: Growth Opportunities for the Global Self-Administered Parenteral Market by Region
  • 6.2: Emerging Trends in the Global Self-Administered Parenteral Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Self-Administered Parenteral Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Self-Administered Parenteral Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Becton, Dickinson and Company
  • 7.2: scPharmaceuticals
  • 7.3: Harro Hofliger
  • 7.4: Owen Mumford
  • 7.5: Haselmeier
  • 7.6: Stevanato Group
  • 7.7: Ypsomed AG
  • 7.8: Solteam Group
  • 7.9: AstraZeneca
  • 7.10: Enable Injections